← FDA Drug Approvals (Drugs@FDA)

VABOMERE

NDA · New Drug Application · Sponsor: REMPEX · Approved 2017-08-29

Drug application

FDA Application #

NDA209776

Application type

New Drug Application

Brand name

VABOMERE

Generic name

MEROPENEM-VABORBACTAM

Active ingredients

MEROPENEM; VABORBACTAM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

REMPEX

Manufacturer

Melinta Therapeutics, LLC

First approval

2017-08-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown